Home > Products > CD3 & IL2R
> Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (Fv-IgG)
Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (Fv-IgG) (CAT#: BSDG-093)
Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD3 IgG with similar domains from an anti-IL2R antibody via short peptide linkers, or vice versa. This BsAb can retarget T cells to tumor cells. It is designed for the research of Hodgkin lymphoma; Non-Hodgkin's lymphoma (NHL); Acute lymphocytic leukemia (ALL) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-IL2R Bispecific Antibody (Fv-IgG) (BSDG-093). Click the button below to contact us or submit your feedback about this product.